Xeinadin appoints Simon Nice as Chief Finance Officer

Date:

Category:

Share this article:

Xeinadin, the Ireland and UK-based business advisory and accountancy firm, has strengthened its leadership team with the appointment of Simon Nice as Chief Financial Officer.

Simon has over 30 years experience in finance having worked for both publicly listed and private firms and joins from Lloyd’s Register where he was Group Director of Finance. Simon has a broad range of experience from designing and implementing global financial strategies to managing corporate M&A and regulatory filings.  

Xeinadin, which was formed in 2019 through the merger of over 100 small and medium-sized accountancy firms, has annual revenues of over £100 million and over 1,500 team members.

Simon will be responsible for leading the firm’s financial operations as it continues its development through acquisitions and organic growth, underpinned by its digital transformation and firm integration programmes.

Simon joins as Xeinadin has bolstered its board with heavyweight hires; Alastair Marsh as Independent Non-Executive Chairman and Robin Williams and Martin Burgess as a Non-Executive Directors.

Derry Crowley, CEO of Xeinadin, commented: “We’re pleased to welcome Simon on board. His experience and knowledge from M&A to financial streamlining for both public and private companies will be invaluable as we work towards building our firm further. Simon joins at an exciting time for the company as we act on our ambitions with a strong and enhanced board and big plans for the future.”

Simon Nice, Chief Financial Officer of Xeinadin, commented: “I’m really looking forward to working with Derry and the team at Xeinadin. The firm has exciting plans and a strong team which it will be great to be part of as we move to the next stage of growth.”

Latest blogs

Nothing was found here.

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

If you opt for acceptance, we will place all cookies. If you opt for rejection, we will only place functional and analytical cookies. You can adjust your preferences at a later time.

Accept Reject More options

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

Functional cookies
Arrow down

Functional cookies are essential for the proper functioning of our website. They allow us to enable basic functions such as page navigation and access to secure areas. These cookies do not collect personal information and cannot be disabled.

Analytical cookies
Arrow down

Analytical cookies help us gain insight into how visitors use our website. We collect anonymised data about page interactions and navigation, enabling us to continuously improve our site.

Marketing cookies
Arrow down

Marketing cookies are used to track visitors when they visit different websites. The goal is to display relevant advertisements to the individual user. By allowing these cookies, you help us show you relevant content and offers.

Accept all Save

Name

Subtitle
Developer
Location
They are focussed on creating a future-focused and relationship-driven culture, that keeps its promises to you, our team members, and partners.
Xeinadin